|Bid||54.11 x 800|
|Ask||54.21 x 900|
|Day's Range||54.01 - 54.01|
|52 Week Range||36.33 - 55.87|
|PE Ratio (TTM)||N/A|
|YTD Daily Total Return||-1.00%|
|Beta (5Y Monthly)||0.00|
|Expense Ratio (net)||0.59%|
Direxion continually reviews its product range to ensure it's meeting the needs of our clients. Based upon a recent review, the Board of Trustees of the Direxion Shares ETF Trust has decided to liquidate and close 15 ETFs (each, a "Fund" and collectively, the "Funds"), based on the recommendation of the Funds' adviser, Rafferty Asset Management, LLC ("Rafferty"). Rafferty believes they cannot continue to operate the Funds in an economically efficient manner, due to the their inability to attract sufficient investment assets. As a result, the Board concluded that liquidating and closing the Funds would be in the best interest of the Funds and their shareholders.
Given the way emerging markets (EM) were roiled by the coronavirus outbreak, it might seem like a sound idea to stay away from them as much as possible. However, a report from global investment firm UBS reminded investors that now might be an opportune time to jump on EM assets.
Confidence restored in emerging markets (EM) assets could be well on its way as the effects of the coronavirus stark to weaken. "The MSCI Emerging Markets Index .MSCIEF, which measures stock performance, has rebounded 4% from its early February low, though it remains down on the year," the report added. For investors looking for the continued upside in emerging market assets as the effects of the coronavirus weaken, the Direxion MSCI Emerging Over Developed Markets ETF (RWED) offers them the ability to benefit not only from emerging markets potentially performing well, but from emerging markets outperforming developed markets.